Results 101 to 110 of about 11,797 (113)

Discipline and resistance on social media: Discourse, power and context in the Paul Chambers ‘Twitter Joke Trial’

Discourse, Context and Media, 2014
Darren Kelsey, Lucy Bennett
exaly  

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Lancet, The, 2016
Ian Jacobs, Usha Menon, Andy Ryan
exaly  

Biomarker enrichment strategies: matching trial design to biomarker credentials

Nature Reviews Clinical Oncology, 2013
Boris Freidlin
exaly  

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Lancet, The, 2012
Peter Sandercock, Joanna M Wardlaw, Richard I Lindley   +2 more
exaly  

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

Lancet, The, 2008
Katalin Darvas, Homer Yang, Gordon Guyatt   +2 more
exaly  

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Ca-A Cancer Journal for Clinicians
Ling-Long Tang, Wen-Fei Li, Xu Liu
exaly  

Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial

Lancet, The, 2016
Rajesh Patel, Janet T Powell, Michael John Sweeting   +2 more
exaly  

Novel clinical trial designs emerging from the molecular reclassification of cancer

Ca-A Cancer Journal for Clinicians
Mina Nikanjam, Shumei Kato, Jason K Sicklick   +2 more
exaly  

Cancer therapy and the randomized clinical trial: good medicine?

Ca-A Cancer Journal for Clinicians, 1994
exaly  

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
Jianqing Zhu, Mo Chen, Ning Li
exaly